Figure 7.
Figure 7. Effects of IAIPs on extracellular ROS production and p47phox phosphorylation in neutrophils. (A) The purified human neutrophils were incubated with different concentrations of IAIPs (12.5, 25, and 100 μg/mL) or HBSS for 30 minutes and the ROS produced extracellularly was determined using isoluminol as a substrate. The chemiluminescence in the medium was determined by FlexStation 3. The time-course changes are shown. Results are expressed as means ± SEM of 6 experiments. (B) The ROS produced extracellularly was determined at 15 minutes in the presence of different concentrations of IAIPs. The results are expressed as means ± SEM of 6 experiments. **P < .01 vs HBSS. (C) The purified human neutrophils were incubated with 25 ng/mL GM-CSF (positive control), HBSS, HSA (1 μM), or IAIPs (100 μg/mL) for 20 minutes at 37°C. Cells were then lysed, and proteins from 4 × 106 cells were analyzed with SDS-PAGE. Western immunoblotting was performed with anti-p47phox and anti-phospho-Ser328 antibodies. (D) Western immunoblots from 3 different experiments were scanned; phosphorylated and total p47phox were quantified by densitometry. Results are expressed as means ± SEM (n = 3). **P < .01 vs HBSS. (E) IAIPs 6.25 μg/mL or 12.5 µg/mL were preincubated with control IgG1 20 µg/mL or IAIP Ab 20 µg/mL for 30 minutes at 37°C. Purified human neutrophils were then incubated with IAIPs for 30 minutes and the ROS produced extracellularly was determined using isoluminol as a substrate. The chemiluminescence in the medium was determined by FlexStation 3. Percentage suppression of ROS can be calculated using the following formula: ((chemiluminescence intensity of cells treated with HBSS or control IgG1 or IAIPs Ab alone [control] − chemiluminescence intensity of cells treated with IAIPs or IAIPs with IgG1 or IAIPs with IAIP Ab)/chemiluminescence intensity of control) × 100. The results are the means ± SEM of 3 experiments. ☥P < .05 IAIPs vs IAIPs + α-IAIP; &P < .05 IAIPs + control IgG vs IAIPs + α-IAIP.

Effects of IAIPs on extracellular ROS production and p47phoxphosphorylation in neutrophils. (A) The purified human neutrophils were incubated with different concentrations of IAIPs (12.5, 25, and 100 μg/mL) or HBSS for 30 minutes and the ROS produced extracellularly was determined using isoluminol as a substrate. The chemiluminescence in the medium was determined by FlexStation 3. The time-course changes are shown. Results are expressed as means ± SEM of 6 experiments. (B) The ROS produced extracellularly was determined at 15 minutes in the presence of different concentrations of IAIPs. The results are expressed as means ± SEM of 6 experiments. **P < .01 vs HBSS. (C) The purified human neutrophils were incubated with 25 ng/mL GM-CSF (positive control), HBSS, HSA (1 μM), or IAIPs (100 μg/mL) for 20 minutes at 37°C. Cells were then lysed, and proteins from 4 × 106 cells were analyzed with SDS-PAGE. Western immunoblotting was performed with anti-p47phox and anti-phospho-Ser328 antibodies. (D) Western immunoblots from 3 different experiments were scanned; phosphorylated and total p47phox were quantified by densitometry. Results are expressed as means ± SEM (n = 3). **P < .01 vs HBSS. (E) IAIPs 6.25 μg/mL or 12.5 µg/mL were preincubated with control IgG1 20 µg/mL or IAIP Ab 20 µg/mL for 30 minutes at 37°C. Purified human neutrophils were then incubated with IAIPs for 30 minutes and the ROS produced extracellularly was determined using isoluminol as a substrate. The chemiluminescence in the medium was determined by FlexStation 3. Percentage suppression of ROS can be calculated using the following formula: ((chemiluminescence intensity of cells treated with HBSS or control IgG1 or IAIPs Ab alone [control] − chemiluminescence intensity of cells treated with IAIPs or IAIPs with IgG1 or IAIPs with IAIP Ab)/chemiluminescence intensity of control) × 100. The results are the means ± SEM of 3 experiments. P < .05 IAIPs vs IAIPs + α-IAIP; &P < .05 IAIPs + control IgG vs IAIPs + α-IAIP.

Close Modal

or Create an Account

Close Modal
Close Modal